Copyright Reports & Markets. All rights reserved.

Global Neurorehabilitation Devices Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Neurorehabilitation Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Implantable Neurorehabilitation System
    • 1.2.3 Neurorobotic System
    • 1.2.4 Brain Computer Interface
    • 1.2.5 Non-invasive Stimulators
    • 1.2.6 Other
  • 1.3 Market by Application
    • 1.3.1 Global Neurorehabilitation Devices Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Neurorehabilitation Devices Market Perspective (2016-2027)
  • 2.2 Neurorehabilitation Devices Growth Trends by Regions
    • 2.2.1 Neurorehabilitation Devices Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Neurorehabilitation Devices Historic Market Share by Regions (2016-2021)
    • 2.2.3 Neurorehabilitation Devices Forecasted Market Size by Regions (2022-2027)
  • 2.3 Neurorehabilitation Devices Industry Dynamic
    • 2.3.1 Neurorehabilitation Devices Market Trends
    • 2.3.2 Neurorehabilitation Devices Market Drivers
    • 2.3.3 Neurorehabilitation Devices Market Challenges
    • 2.3.4 Neurorehabilitation Devices Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Neurorehabilitation Devices Players by Revenue
    • 3.1.1 Global Top Neurorehabilitation Devices Players by Revenue (2016-2021)
    • 3.1.2 Global Neurorehabilitation Devices Revenue Market Share by Players (2016-2021)
  • 3.2 Global Neurorehabilitation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Neurorehabilitation Devices Revenue
  • 3.4 Global Neurorehabilitation Devices Market Concentration Ratio
    • 3.4.1 Global Neurorehabilitation Devices Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation Devices Revenue in 2020
  • 3.5 Neurorehabilitation Devices Key Players Head office and Area Served
  • 3.6 Key Players Neurorehabilitation Devices Product Solution and Service
  • 3.7 Date of Enter into Neurorehabilitation Devices Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Neurorehabilitation Devices Breakdown Data by Type

  • 4.1 Global Neurorehabilitation Devices Historic Market Size by Type (2016-2021)
  • 4.2 Global Neurorehabilitation Devices Forecasted Market Size by Type (2022-2027)

5 Neurorehabilitation Devices Breakdown Data by Application

  • 5.1 Global Neurorehabilitation Devices Historic Market Size by Application (2016-2021)
  • 5.2 Global Neurorehabilitation Devices Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Neurorehabilitation Devices Market Size (2016-2027)
  • 6.2 North America Neurorehabilitation Devices Market Size by Type
    • 6.2.1 North America Neurorehabilitation Devices Market Size by Type (2016-2021)
    • 6.2.2 North America Neurorehabilitation Devices Market Size by Type (2022-2027)
    • 6.2.3 North America Neurorehabilitation Devices Market Size by Type (2016-2027)
  • 6.3 North America Neurorehabilitation Devices Market Size by Application
    • 6.3.1 North America Neurorehabilitation Devices Market Size by Application (2016-2021)
    • 6.3.2 North America Neurorehabilitation Devices Market Size by Application (2022-2027)
    • 6.3.3 North America Neurorehabilitation Devices Market Size by Application (2016-2027)
  • 6.4 North America Neurorehabilitation Devices Market Size by Country
    • 6.4.1 North America Neurorehabilitation Devices Market Size by Country (2016-2021)
    • 6.4.2 North America Neurorehabilitation Devices Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Neurorehabilitation Devices Market Size (2016-2027)
  • 7.2 Europe Neurorehabilitation Devices Market Size by Type
    • 7.2.1 Europe Neurorehabilitation Devices Market Size by Type (2016-2021)
    • 7.2.2 Europe Neurorehabilitation Devices Market Size by Type (2022-2027)
    • 7.2.3 Europe Neurorehabilitation Devices Market Size by Type (2016-2027)
  • 7.3 Europe Neurorehabilitation Devices Market Size by Application
    • 7.3.1 Europe Neurorehabilitation Devices Market Size by Application (2016-2021)
    • 7.3.2 Europe Neurorehabilitation Devices Market Size by Application (2022-2027)
    • 7.3.3 Europe Neurorehabilitation Devices Market Size by Application (2016-2027)
  • 7.4 Europe Neurorehabilitation Devices Market Size by Country
    • 7.4.1 Europe Neurorehabilitation Devices Market Size by Country (2016-2021)
    • 7.4.2 Europe Neurorehabilitation Devices Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Neurorehabilitation Devices Market Size (2016-2027)
  • 8.2 Asia-Pacific Neurorehabilitation Devices Market Size by Type
    • 8.2.1 Asia-Pacific Neurorehabilitation Devices Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Neurorehabilitation Devices Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Neurorehabilitation Devices Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Neurorehabilitation Devices Market Size by Application
    • 8.3.1 Asia-Pacific Neurorehabilitation Devices Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Neurorehabilitation Devices Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Neurorehabilitation Devices Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Neurorehabilitation Devices Market Size by Region
    • 8.4.1 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Neurorehabilitation Devices Market Size (2016-2027)
  • 9.2 Latin America Neurorehabilitation Devices Market Size by Type
    • 9.2.1 Latin America Neurorehabilitation Devices Market Size by Type (2016-2021)
    • 9.2.2 Latin America Neurorehabilitation Devices Market Size by Type (2022-2027)
    • 9.2.3 Latin America Neurorehabilitation Devices Market Size by Type (2016-2027)
  • 9.3 Latin America Neurorehabilitation Devices Market Size by Application
    • 9.3.1 Latin America Neurorehabilitation Devices Market Size by Application (2016-2021)
    • 9.3.2 Latin America Neurorehabilitation Devices Market Size by Application (2022-2027)
    • 9.3.3 Latin America Neurorehabilitation Devices Market Size by Application (2016-2027)
  • 9.4 Latin America Neurorehabilitation Devices Market Size by Country
    • 9.4.1 Latin America Neurorehabilitation Devices Market Size by Country (2016-2021)
    • 9.4.2 Latin America Neurorehabilitation Devices Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Neurorehabilitation Devices Market Size (2016-2027)
  • 10.2 Middle East & Africa Neurorehabilitation Devices Market Size by Type
    • 10.2.1 Middle East & Africa Neurorehabilitation Devices Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Neurorehabilitation Devices Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Neurorehabilitation Devices Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Neurorehabilitation Devices Market Size by Application
    • 10.3.1 Middle East & Africa Neurorehabilitation Devices Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Neurorehabilitation Devices Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Neurorehabilitation Devices Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Neurorehabilitation Devices Market Size by Country
    • 10.4.1 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Medtronic
    • 11.1.1 Medtronic Company Details
    • 11.1.2 Medtronic Business Overview
    • 11.1.3 Medtronic Neurorehabilitation Devices Introduction
    • 11.1.4 Medtronic Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.1.5 Medtronic Recent Development
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Neurorehabilitation Devices Introduction
    • 11.2.4 Abbott Laboratories Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.2.5 Abbott Laboratories Recent Development
  • 11.3 Boston Scientific
    • 11.3.1 Boston Scientific Company Details
    • 11.3.2 Boston Scientific Business Overview
    • 11.3.3 Boston Scientific Neurorehabilitation Devices Introduction
    • 11.3.4 Boston Scientific Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.3.5 Boston Scientific Recent Development
  • 11.4 Bioness
    • 11.4.1 Bioness Company Details
    • 11.4.2 Bioness Business Overview
    • 11.4.3 Bioness Neurorehabilitation Devices Introduction
    • 11.4.4 Bioness Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.4.5 Bioness Recent Development
  • 11.5 Hocoma AG
    • 11.5.1 Hocoma AG Company Details
    • 11.5.2 Hocoma AG Business Overview
    • 11.5.3 Hocoma AG Neurorehabilitation Devices Introduction
    • 11.5.4 Hocoma AG Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.5.5 Hocoma AG Recent Development
  • 11.6 Neuronetics
    • 11.6.1 Neuronetics Company Details
    • 11.6.2 Neuronetics Business Overview
    • 11.6.3 Neuronetics Neurorehabilitation Devices Introduction
    • 11.6.4 Neuronetics Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.6.5 Neuronetics Recent Development
  • 11.7 Yiruide
    • 11.7.1 Yiruide Company Details
    • 11.7.2 Yiruide Business Overview
    • 11.7.3 Yiruide Neurorehabilitation Devices Introduction
    • 11.7.4 Yiruide Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.7.5 Yiruide Recent Development
  • 11.8 Magstim
    • 11.8.1 Magstim Company Details
    • 11.8.2 Magstim Business Overview
    • 11.8.3 Magstim Neurorehabilitation Devices Introduction
    • 11.8.4 Magstim Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.8.5 Magstim Recent Development
  • 11.9 VISHEE
    • 11.9.1 VISHEE Company Details
    • 11.9.2 VISHEE Business Overview
    • 11.9.3 VISHEE Neurorehabilitation Devices Introduction
    • 11.9.4 VISHEE Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.9.5 VISHEE Recent Development
  • 11.10 Ekso Bionics
    • 11.10.1 Ekso Bionics Company Details
    • 11.10.2 Ekso Bionics Business Overview
    • 11.10.3 Ekso Bionics Neurorehabilitation Devices Introduction
    • 11.10.4 Ekso Bionics Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.10.5 Ekso Bionics Recent Development
  • 11.11 Alter G
    • 11.11.1 Alter G Company Details
    • 11.11.2 Alter G Business Overview
    • 11.11.3 Alter G Neurorehabilitation Devices Introduction
    • 11.11.4 Alter G Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.11.5 Alter G Recent Development
  • 11.12 MagVenture
    • 11.12.1 MagVenture Company Details
    • 11.12.2 MagVenture Business Overview
    • 11.12.3 MagVenture Neurorehabilitation Devices Introduction
    • 11.12.4 MagVenture Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.12.5 MagVenture Recent Development
  • 11.13 Tyromotion
    • 11.13.1 Tyromotion Company Details
    • 11.13.2 Tyromotion Business Overview
    • 11.13.3 Tyromotion Neurorehabilitation Devices Introduction
    • 11.13.4 Tyromotion Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.13.5 Tyromotion Recent Development
  • 11.14 Soterix Medical
    • 11.14.1 Soterix Medical Company Details
    • 11.14.2 Soterix Medical Business Overview
    • 11.14.3 Soterix Medical Neurorehabilitation Devices Introduction
    • 11.14.4 Soterix Medical Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.14.5 Soterix Medical Recent Development
  • 11.15 Neuroelectrics
    • 11.15.1 Neuroelectrics Company Details
    • 11.15.2 Neuroelectrics Business Overview
    • 11.15.3 Neuroelectrics Neurorehabilitation Devices Introduction
    • 11.15.4 Neuroelectrics Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.15.5 Neuroelectrics Recent Development
  • 11.16 Bionik Laboratories
    • 11.16.1 Bionik Laboratories Company Details
    • 11.16.2 Bionik Laboratories Business Overview
    • 11.16.3 Bionik Laboratories Neurorehabilitation Devices Introduction
    • 11.16.4 Bionik Laboratories Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.16.5 Bionik Laboratories Recent Development
  • 11.17 Helius Medical
    • 11.17.1 Helius Medical Company Details
    • 11.17.2 Helius Medical Business Overview
    • 11.17.3 Helius Medical Neurorehabilitation Devices Introduction
    • 11.17.4 Helius Medical Revenue in Neurorehabilitation Devices Business (2016-2021)
    • 11.17.5 Helius Medical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Neurorehabilitation Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurorehabilitation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Implantable Neurorehabilitation System
    Neurorobotic System
    Brain Computer Interface
    Non-invasive Stimulators
    Other

    Segment by Application
    Hospitals
    Clinics
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Medtronic
    Abbott Laboratories
    Boston Scientific
    Bioness
    Hocoma AG
    Neuronetics
    Yiruide
    Magstim
    VISHEE
    Bioness
    Hocoma AG
    MagVenture
    Tyromotion
    Soterix Medical
    Neuroelectrics
    Bionik Laboratories

    Buy now